论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Chen D, Zhan Y, Peng J, Yao F
Received 1 November 2018
Accepted for publication 12 March 2019
Published 17 April 2019 Volume 2019:12 Pages 2937—2941
DOI https://doi.org/10.2147/OTT.S193014
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 3
Editor who approved publication: Dr Takuya Aoki
Abstract: Richter’s
syndrome, the development of high-grade non-Hodgkin lymphoma in patients with
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), may be
triggered by viral infections (eg, Epstein–Barr virus infection). Herein, we
report an unusual case of CD5-negative CLL/SLL patient with gastrointestinal
mantle cell lymphoma (MCL) and hepatitis B virus infection. CLL/SLL was
diagnosed based on lymph node immunohistochemistry and bone marrow pathology.
This patient was treated with seven cycles of multi-agent chemotherapy. During
treatment, the hepatitis B viruses were activated. Then, after 20 months of
antiviral treatment with entecavir, he developed abdominal discomfort and
abdominal lymphadenopathy and was diagnosed with MCL based on intestinal
biopsy. This work indicates that the hepatitis B virus in patients with CLL/SLL
may accelerate the progress or transformation to MCL.
Keywords: Richter’s
syndrome, chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell
lymphoma, hepatitis B virus infection
